Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism

International Journal of Obesity

Volumn 39, Issue 10, 2015, Pages 1539-1547

  Dakin, R S ^a   Walker, B R ^a   Seckl, J R ^a   Hadoke, P W F ^a   Drake, A J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CHOLESTEROL; CORTICOSTERONE; ESTRADIOL; GLUCOCORTICOID; GLUCOSE; INSULIN; LIPID; TESTOSTERONE; TRIACYLGLYCEROL; ESTROGEN; ESTROGEN RECEPTOR;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; CORTICOSTERONE BLOOD LEVEL; DIET INDUCED OBESITY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; LIPID DIET; LIPID METABOLISM; LIVER; METABOLISM; OBESITY;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GLUCOCORTICOIDS; GLUCOSE TOLERANCE TEST; INFLAMMATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; RECEPTORS, ESTROGEN;

EID: 84943453292     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.102     Document Type: Article

References (58)

1. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr. 2007; 85: 1197-1202.
2. Kautzky-Willer A, Handisurya A. Metabolic diseases and associated complications: sex and gender matter!. Eur J Clin Invt. 2009; 39: 631-648.
3. Noonan WT, Banks RO. Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus. Proc Soc Exp Biol Med. 2000; 225: 221-223.
4. Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K. Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL/6J and BALB/cA mice. Exp Anim. 2007; 56: 263-272.
5. Hwang LL, Wang CH, Li TL, Chang SD, Lin LC, Chen CP, et al. Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity. 2010; 18: 463-469.
6. Stubbins R, Holcomb V, Hong J, Núñez N. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutrition. 2012; 51: 861-870.
7. Maher MA, Banz WJ, Truett GE, Zemel MB. Dietary fat and sex modify heterozygote effects of the rat Fatty (fa) allele. J Nutr. 1996; 126: 2487-2493.
8. Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis. 2000; 148: 231-241.
9. Donahue RP, Bean JA, Donahue RA, Goldverg RB, Prineas RJ. Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care. 1997; 20: 1670-1676.
10. Nuutila P, Knuuti MJ, Mäki M, Laine H, Ruotsalainen U, Teräs M, et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes. 1995; 44: 31-36.
11. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 88: 2404-2411.
12. Finkelstein JS, Lee H, Burnett-Bowie S-AM, Pallais JC, Yu EW, Borges LF, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013; 369: 1011-1022.
13. Fox CS, Yang Q, Cupples LA, Guo C-Y, Atwood LD, Murabito JM, et al. Sex-specific association between estrogen receptor-A gene variation and measures of adiposity: The Framingham Heart Study. J Clin Endocrinol Metab. 2005; 90: 6257-6262.
14. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metabol. 2004; 89: 61-70.
15. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994; 331: 1056-1061.
16. Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci USA. 1998; 95: 4061-4065.
17. Holmes MC, French KL, Seckl JR. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Brain Res Mol Res. 1995; 28: 186-192.
18. Norris AW, Chen L, Fisher SJ, Szanto I, Ristow M, Jozsi AC, et al. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest. 2003; 112: 608-618.
19. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology. 2000; 141: 560-563.
20. King V, Dakin RS, Liu L, Hadoke PW, Walker BR, Seckl JR, et al. Maternal obesity has little effect on the immediate offspring but impacts on the next generation. Endocrinology. 2013; 154: 2514-2524.
21. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, et al. Tissuespecific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab. 2001; 86: 1418-1421.
22. Kotani K, Tiokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Dis. 1994; 18: 207-212.
23. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and nongenomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005; 280: 35983-35991.
24. Riant E, Waget A, Cogo H, Arnal J-F, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009; 150: 2109-2117.
25. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993; 328: 1069-1075.
26. Zhu L, Martinez MN, Emfinger CH, Palmisano BT, Stafford JM. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am J Physiol Endocrinol Metab. 2014; 306: E1188-E1197.
27. Camporez JPG, Jornayvaz FR, Lee H-Y, Kanda S, Guigni BA, Kahn M, et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology. 2013; 154: 1021-1028.
28. Zhu L, Brown WC, Cai Q, Krust A, Chambon P, McGuinness OP, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes. 2013; 62: 424-434.
29. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013; 34: 309-338.
30. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-A knockout mice. Proc Natl Acad Sci USA. 2000; 97: 12729-12734.
31. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, et al. Evidence that oestrogen receptor-A plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006; 49: 588-597.
32. Wang X, Lu Y, Wang E, Zhang Z, Xiong X, Zhang H, et al. Hepatic estrogen receptor a improves hepatosteatosis through up-regulation of small heterodimer partner. J Hepatol. 2015; e-pub ahead of print 24 February. 2015; doi:10.1016/.j.jhep.2015.02.029.
33. Auvinen HE, Romijn JA, Biermasz NR, Pijl H, Havekes LM, Smit JWA, et al. The effects of high fat diet on the basal activity of the hypothalamus-pituitary-Adrenal axis in mice. J Endocrinol. 2012; 214: 191-197.
34. Drake AJ, Livingstone DEW, Andrew R, Seckl JR, Morton NM, Walker BR. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology. 2005; 146: 913-919.
35. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol. 2007; 157: 545-559.
36. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 2002; 87: 3330-3336.
37. Paulsen SK, Pedersen SB, Fisker S, Richelsen B. 11beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity and fat localisation. Obesity. 2007; 15: 1954-1960.
38. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11betahydroxysteroid dehydrogenase type 1. J Endocrinol. 1999; 160: 103-109.
39. Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Zhou MY, Toroslu C, et al. Regulation of 11β-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am J Physiol. 2003; 285: E272-E279.
40. Tagawa N, Yuda R, Kubota S, Wakabayashi M, Yamaguchi Y, Kiyonaga D, et al. 17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes. J Endocrinol. 2009; 202: 131-139.
41. Andersson T, Simonyte K, Andrew R, Strand M, Bur?n J, Walker BR, et al. Tissuespecific increases in 11β-Hydroxysteroid Dehydrogenase Type 1 in normal weight postmenopausal women. PLoS ONE. 2009; 4: e8475.
42. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001; 294: 2166-2170.
43. Morton NM, Ramage LE, Seckl JR. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: A potential adaptive mechanism counteracting metabolic disease. Endocrinology. 2004; 145: 2707-2712.
44. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA. 1997; 94: 14924-14929.
45. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11betahydroxysteroid dehydrogenase type 1 null mice. J Biol Chem2001; 276: 41293-41300.
46. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, et al. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology. 2003; 144: 4755-4762.
47. Berthiaume M, Laplante M, Festuccia W, Gélinas Y, Poulin S, Lalonde J, et al. Depotspecific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1. Endocrinology. 2007; 148: 2391-2397.
48. Chapman KE, Kotelevtsev YV, Jamieson PM, Williams LJ, Mullins JJ, Seckl JR. Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases. Biochem Soc Trans. 1997; 25: 583-587.
49. McInnes KJ, Kenyon CJ, Chapman KE, Livingstone DEW, Macdonald LJ, Walker BR, et al. 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. J Biol Chem. 2004; 279: 22908-22912.
50. Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 1998; 83: 1806-1809.
51. Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity. 2008; 16: 731-735.
52. Stimson RH, Mohd-Shukri NA, Bolton JL, Andrew R, Reynolds RM, Walker BR. The postprandial rise in plasma cortisol in men is mediated by macronutrient-specific stimulation of adrenal and extra-Adrenal cortisol production. J Clin Endocrinol Metab. 2014; 99: 160-168.
53. Stimson RH, Andrew R, McAvoy NC, Tripathi D, Hayes PC, Walker BR. Increased whole-body and sustained liver cortisol regeneration by 11β-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Diabetes. 2011; 60: 720-725.
54. Wake DJ, Homer NZM, Andrew R, Walker BR. Acute in vivo regulation of 11β-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J Clin Endocrinol Metab. 2006; 91: 4682-4688.
55. Livingstone DE, McInnes KJ, Walker BR, Andrew R. Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obes Res. 2005; 13: 1523-1526.
56. Andersson B, Mattsson L-Å, Hahn L, MÅrin P, Lapidus L, Holm G, et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulindependent diabetes mellitus. J Clin Endocrinol Metab. 1997; 82: 638-643.
57. Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead MI, Stevenson JC. Effects of oral and transdermal 17β-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism. 2000; 49: 742-747.
58. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care. 1998; 21: 1589-1595.